BCG remains the only widely available vaccine for TB. Yet the development of a COVID-19 vaccine over the last year shows that there is capacity to rapidly create new vaccines.
Emily B. Wong, Africa Health Research Institute (AHRI) y Alison Grant, Africa Health Research Institute (AHRI)
South Africa’s long-awaited TB prevalence survey results were recently released. They reveal that the country has a much higher burden of TB than previously thought.